MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project

MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas... J Neurooncol (2017) 134:241–242 DOI 10.1007/s11060-017-2500-2 LETTER TO THE EDITOR MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project 1 2 1 Mo Yang  · Harrison X. Bai  · Li Yang   Received: 28 November 2016 / Accepted: 20 May 2017 / Published online: 25 May 2017 © Springer Science+Business Media New York 2017 To the Editor, miRNA-21 expression, age and KPS score were treated as continuous variables, while tumor grade and IDH1/2 We read with great interest a recent study by Li et al. on the mutant status were treated as ordinal variables. Statistical prognostic value of microRNA-21 in gliomas [1]. By per- analysis was performed using SPSS version 22 (Interna- forming a meta-analysis of relevant published literature, the tional Business Machines Corporation, Armonk, NY). authors found that high miRNA-21 expression was associ- We included 244 patients in our cohort, among which ated with lower overall survival (OS) in both gliomas and 105 were grade II tumors and 139 were grade III tumors. GBM. First, each miRNA-21 expression was factored into a mul- We conducted a similar analysis using lower-grade tivariable Cox proportional hazards model with age, KPS, glioma (LGG) dataset from the Cancer Genome Atlas IDH mutant status and tumor http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Neuro-Oncology Springer Journals

MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project

Loading next page...
 
/lp/springer_journal/microrna-21-expression-in-the-prognosis-of-low-grade-gliomas-data-from-06akzhH2nT
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Oncology; Neurology
ISSN
0167-594X
eISSN
1573-7373
D.O.I.
10.1007/s11060-017-2500-2
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial